Preventive treatment criteria were met by 90.9% in 2023 versus 75.0% in 2017
The commonly cited factors for people with T2D and physicians include fear of hypoglycaemia, weight gain and the plethora of treatment options with increasing management complexity [3]
Our team will offer personalized guidance to help you make informed choices about your health journey
Our cutting-edge electronic PRO (ePRO) solutions ensure your clinical trials generate high-quality, reliable evidence to support regulatory approvals and demonstrate real-world patient benefits
What is your risk tolerance
This might be targeting angiogenesis and NOs cytotoxic and damaging actions but maintaining, promoting, or recovering their essential protective functions [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40]